Cannabis hyperemesis syndrome is not well understood, and seems to be a new illness that mostly affects heavy cannabis users. Since the first recorded case in 2004, much has been speculated about this mysterious and literally sickening syndrome. Is it cannabis intolerance? Is it neem oil poisoning? And what’s with the hot baths?
Medicinal cannabis for pets? It may sound a bit strange initially, but when you think about it, it actually makes a lot of sense. Dogs, for example, have more cannabinoid receptors than any other animals. This presents both opportunities and risks. Here is our report on our investigation into the world of “pot for pets”.
As the way to someone’s heart is through their stomach, it’s no surprise that cooking and baking with cannabis is growing in popularity. In order to enjoy their pharmacological effects, THC and CBD need to be decarboxylated. To put it another way: no heat, no buzz!
Cannabis contains over 500 constituents. The most important of these are THC (tetrahydrocannabinol) and CBD (cannabidiol), which both belong to the cannabinoid group. Unlike THC, CBD does not make you high. It does however offer great medicinal potential. That is one of the reasons that we have seen a real boom in CBD over the last few years.
Cannabinoids are naturally present in plants of the Cannabis Sativa L. species. We ingest them when consuming cannabis or hemp – more or less depending on what exactly is consumed, and how. The human body also produces cannabinoids, and there are many ways we are still discovering their properties, benefits, and manifestations.
The production, sale and export of medicinal marijuana are strictly regulated. Despite this, patients know less about the contents and origins of their medication than recreational users. Why is this and what could be improved?
Clinical endocannabinoid deficiency (CEDC) is a proposed spectrum disorder that has been implicated in a range of illnesses, including fibromyalgia, migraine and irritable bowel syndrome. So far, very little research has been conducted on this speculative disorder, but if it is found to exist, it could be responsible for these very common conditions as well as many related ones.
In this third and final video of the Colombia series, Cannabis News Network explains the situation unfolding in the region of Cauca, where cannabis is being massively produced to prepare for the incoming legal medicinal cannabis legislation. Check out this ultimate episode that shows you what goes on behind the scenes of fair trade cannabis.
The list of diseases for which the phytocannabinoids in the Cannabis Sativa L. plant have medicinal properties and benefits does not stop getting longer. Now, an international study shows that Tetrahydrocannabinolic acid or THCA, which is found in raw cannabis, has important neuroprotective effects.
With the new law on cannabis as a medicine, medicinal cannabis became marketable in Germany. Since then, it has been possible to bring it with you to other European countries. Read about what you need to consider here.
Tetrahydrocannabivarin (THCV) is one of the most medically important of the known cannabinoids. It is thought to act as an antagonist of the cannabinoid receptors at low doses, but surprisingly, it may act as an agonist at high doses, giving effects similar to THC. Since its discovery in 1973, THCV has gradually grown in importance within medical circles.
Medicinal cannabis is becoming more and more accepted the world over, as an increasing number of countries is moving towards a health-focused approach to the plant. Good news for patients, one would say. But the fight isn’t over yet, as shown in this report from Cannabis News Network.
Cannabidivarin (CBDV) is a naturally-occurring phytocannabinoid that occurs in small traces in certain strains of the cannabis plant. Although less studied than its more famous counterparts such as THC and CBD, research is beginning to uncover the medical potential of CBDV to treat epilepsy and other neurological conditions.
While just a few years ago, it was still taboo to talk about legalising cannabis in Morocco and Tunisia, nowadays, everyone is talking about it.
Cannabis advocacy continues to progress in 2017 with news that has given the cannabis community grounds for optimism. WHO will conduct its 1st official evaluation of cannabis' medicinal value. If the results are favourable, the stringent international restrictions on cannabis may ease and cannabis may finally be reclassified. Read more.
In February 2017, Ciudadanos and the OECM presented a Non-Legislative Motion in Congress in order to regulate medical cannabis in Spain. Its objective is to address the needs and demands of Spanish patients, as well as to open a parliamentary debate about therapeutic cannabis – a treatment backed by scientific evidence.
The political discussion around cannabis keeps returning to the results of studies. Now that the opponents of cannabis are faced with the positive experiences in many US states, Uruguay and Canada, their arguments are petering out, so instead, they have begun referring to what they claim is a lack of results from studies on cannabis. So far...
Opponents of cannabis like to call it a gateway drug. They say it is just one of many illegal substances, a launch pad toward a druggie lifestyle. Although this theory has long been disproved scientifically, this alternative fact is repeated endlessly like a mantra by opponents of legalisation. But what about withdrawal treatment? More on that.
On 20 February, the South African media reported that the country's government will soon be issuing the first licences permitting the production of medicinal cannabis in South Africa.